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ridge building in the global world of public health
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pnfectious diseases have played a substantial part
n shaping human history. In lessons around the
orld, school children still learn about the 1918
panish Flu (also known as Asian ﬂu), and its deci-
ation of lives in the aftermath of the Great War.
ow, in this era of the ‘‘Flat World’’, globalization
as facilitated the spread of numerous infectious
gents to all corners of the planet. No locale is
oo remote from a threatening pathogen, whether
estern Nile Virus arriving to the United States or
ift Valley fever reaching the Arabian Peninsula.
he roles played by travel, migration trade, and
uman exchanges in the propagation of epidemic
nfectious disease have been clearly demonstrated.
ajj-related infection is an emerging subspecialty
n global epidemiology with this issue reporting the
ollaboration between public health workers and
ommunity leaders in London to curtail a cluster
utbreak of W135 meningococcal meningitis. Else-
here, worrying rises in HIV disease in inner cities
re on the increase as social behaviours change in
he security of available antiretrovirals.
Public health risks focus on infectious agents
oth speciﬁc to humans (which are broadly and
niformly distributed) and zoonoses, which are far
ore localized in their geographical distribution.
esearch has shown that emerging infectious dis-
ases have roughly quadrupled over the past 50
ears, and pathogens that originate in wild ani-
als (wildlife zoonoses) account for the majority of
uch diseases. The frequency of infectious disease
mergence correlates highly with human popula-
ion density, the density of mammalian species, and
uman population growth.
Experiences with Avian Inﬂuenza in China are
recent example which was further ampliﬁed in
he setting of intense population densities. Popu-
ation surges exploding at a speed exceeding even
ccelerated development in societies like India and
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oi:10.1016/j.jiph.2008.08.007hina are a particularly combustible arena. Hajj
elated infectious disease and the setting of the
nnual, ever dynamic timing of Hajj season threat-
ns to ignite a global inﬂuenza pandemic, driving
remendous innovation.
Around the world, policy makers and health
uthorities rightly hold serious concern for safe-
uarding both domestic and international public
ealth, often with limited resources which can-
ot expand to support unanticipated epidemics.
resently, nations are left to determining which
nfectious agents have the greatest potential to
stablish within their borders and then manage
hem often alone and unsupported. This must
hange and actors are pressing for acceleration
owards imaginative collaborative approaches. At
he advent of a century characterized by an appar-
nt increase in emerging infectious diseases (EID),
hese events have critical implications for public-
ealth policy and the future research pathways
f infectious disease ecology. Responses must be
ought not only from conventional, international
odies such as the WHO, agencies which are already
ver burdened with an exploding population in
he developing world, but also by hybrid organi-
ations which solve problems innovatively and in
ovel constructs. Private investors are assuming
oles previously left to governments. The Gates
oundation and its relationship to TB treatment
nd HIV prevention is perhaps a foremost model
or others to emulate. In this region, similar phi-
anthropy is fostered by individuals with speciﬁc
oncerns for Public Health, including HRH Prince
l Waleed bin Talal who sponsors multiple health
rojects in Africa. Some of these private bodies
ltimately inﬂuence governmental policy through
ffective lobbying groups; president Bill Clinton’s
ersonal interventions with US Pharmaceutical lob-
ies have resulted in affordable anti-retroviral
Saud Bin Abdulaziz University for Health Sciences. All rights reserved.
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therapy in South Africa saving a generation of
children.
EIDs are a signiﬁcant burden on global economies
and public health. They can no longer be man-
aged by government alone. While their emergence
is thought to be driven largely by socio-economic,
environmental and ecological factors, in the dig-
ital age, epidemics portrayed as pandemics in a
ratings-conscious media are particularly emphatic
in their impact. The brief SARS epidemic trans-
planted to Canada by air travellers had an acute
economic impact on the provinces affected even in
this wealthy country. Tourism plummeted. Hospitals
reached capacity straining other services. Emerging
infectious disease, because of our ‘ﬂat’ globalized
world can shake not only the media but the market,
whether the stock market or the tourism indus-
try or the health care industry. Even more sinister,
bioterrorism has gone from a ﬁgment of imagination
in a B-rated movie to a real destabilizer in frag-
ile times: recall the post 9—11 Anthrax assault in
the United States and the paralysis of the mailing
system. Rapid transmission of novel pathogens in
naïve environments has an amplifying ‘echocham-
ber effect’ multiplying impacts in many dimensions,
ever-increasing the pressure to anticipate or worse,
contain, the outbreaks. Yet there is a silver lining to
these dark clouds. The concept of new and emerg-
ing diseases has captured the public interest and
has revitalized the public health infectious disease
community. Private benefactors have entered the
role of grant makers. Pharmaceutical developments
are hastened in the acute crisis of containment,
often with international collaboration—–foot and
mouth disease in the United Kingdom being a prime
example of supercharged multinational develop-
ments resulting in rapid containment. And an era
of global health diplomacy is emerging reviving the
inﬂuence academia can play in the global geopoli-
tik, literally bridging communities into a fabric of
collaborative cooperation.
Nevertheless even the most sincere attempts
to ﬁnd shared solutions can often be hindered.
The differences in public health as a discipline
and overall healthcare delivery systems vary widely
between developed and developing nations, with
divergence in the dual currencies of both available
expertise and preventative therapeutic armamen-
tarium. Often, each follows the other in concert:
an advanced society possesses vast intellectual and
infrastructure assets and a less advanced is limited
in both dimensions. For now, most of the emerging
and re-emerging infectious diseases are problems
of the developing world and touch the developed
world relatively superﬁcially. This may not always
be the case. Those of us in developed societies are
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n the unique role of inﬂuencing global health and
ust now rise to the occasion. There can be no glass
ouses in the world of public health. Instead we
ust build a world of bridges, and quickly.
There is no doubt that infectious diseases are
till inﬂuencing our world today. There is a long list
f outbreaks causing substantial morbidity and mor-
ality in humans and often in the reservoir animal
pecies. Only a few are mentioned above. But sev-
ral of these agents have the potential to grow into
ajor, economically crippling epidemics. Occasion-
lly these may eclipse with a setting of natural
isasters, perhaps earthquake ravaged deltas or
eninsulas devastated in the wake of Tsunamis.
While there are many determinants that inﬂu-
nce the emergence of diseases of concern, the
eed to advance our current understanding of the
ature of agent persistence and spread is becom-
ng increasingly urgent. Several distinctive efforts
ome to mind: multilateral training programs
o unify international infection control medicine
chieved through international training are criti-
al deﬁciency at present. This must be redressed.
uch regional and national cooperation in domes-
ic efforts at epidemiologic surveillance for key
athogens and strategies for coping with possible
cenarios is now required. Each nation no matter
ow dwarfed by major engines of scientiﬁc devel-
pment have distinct roles to play, roles that can
e nurtured in a climate of collaborative compe-
ition. Umbrella organizations with concentrated
xpertise and speciﬁc access to unique resources
hich traverse borders like the Gulf Coopera-
ion Council Center for Infection Control or the
DC’s outreach programs are more vital than ever.
he World Health Organization recently released
evised International Health Regulations (IHR) to
erve as global legislation and provide guidelines
or such surveillance systems.
If we consider this a little further, the IHR aim
o identify and prevent spread of these infec-
ious diseases; however, there are some practical
hallenges that limit the usability of these reg-
lations. IHR requires Member States to build
ecessary infrastructure for global surveillance,
hich may not be possible in underdeveloped
ountries. Developing countries require increased
ssistance in setting up and maintaining these
urveillance systems. These efforts must be sup-
orted by a marriage between private and public
ector research funding and public health education
fforts, whether in a medical school or a school of
ublic health and when these international agen-
ies divest their expertise, a trained and expert
ersonnel must be ready and available to maximally
eneﬁt at a time of crisis.
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Furthermore, public health affects the public
nd must be translated at every level for an
ffective collective response. Unique experiences
osting recurrent mass gatherings, foremost being
he Hajj, are effectively vast, dynamic, as yet
ntapped laboratories which must be examined to
ield vital insights in limiting and managing poten-
ial public health calamities. The ﬁeld of Hajj
edicine is here and leaders to spearhead progress
n this speciﬁc realm of public health are awaited.
ho will assume this hefty mantle? Judicious use of
accine stockpiles and antivirals must be planned
ot in a vacuum but within a climate of transparent
ollaboration. This requires relationships between
ealth care experts, ‘‘Big Pharma’’, and govern-
ent agencies under the patronage of activism,
ften political in nature. Incentives must be iden-
iﬁed to foster such extraordinary collaboration.
nvestments in these efforts must be shared and
he stewardship of each preventive prize vigilantly
hampioned.
If we are to improve the public health response
o future outbreaks of infectious diseases, we must
nticipate the emergence of new infectious dis-
ases, with full understanding that strategies for
∗
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ontaining known infectious diseases may provide
nvaluable models for containing new ones. Multina-
ional cooperation and collaboration through global
ublic health surveillance is critical for the identiﬁ-
ation and prevention of emerging and re-emerging
nfectious diseases. In fact public health policy
akers are already leaders in the emerging disci-
line of global health diplomacy which may likely
e the only way health can be preserved on an
ncreasingly strained planet. Much work needs to
e done and this Journal looks forward to recording,
ollating and learning from our collaborative inter-
ational efforts in defeating man’s ever-present
ompanion: infection.
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